The table below shows Cullinan Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$42.12M
$41.97M
$61.03M
$41.46M
$35.51M
$36.26M
SG&A
CGEM annual revenue (10-K history)
Cullinan Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2022. That is down 100.0% from $18.94M in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.
